A California jury rendered a $5.6 million dollar verdict against Johnson & Johnson’s Ethicon Unit in the first trial against the TVT Abbrevo in Kern County, California. Jurors found the manufacturer was liable for design defect and for failing to warn about its risk to Coleen Perry. Ms. Perry was implanted with the Ethicon TVT Abbrevo in 2011, and she began having a “pulling-type” pain after her implantation surgery.
Click here to read the full article: Johnson & Johnson ordered to pay $5.7 million in California mesh trial
The above article was corrected to show that the verdict was $5.6 million. CORRECTED-Johnson & Johnson ordered to pay $5.6 mln in California mesh trial
The jury awarded $700,000 in compensatory damages and $5 million in punitive damages against the pharmacy giant.
The case is Perry et al v. Luu et al, Superior Court of the State of California, Kern County, No. 5-1500-CV-279123.
Vaginal Mesh Trial History
Bard has lost two jury trials, settled a third case after a jury selected, and settled a fourth before trial commenced. In July 2012, a California jury awarded Christine Scott and her husband $5.5 million after she underwent nine revision surgeries. Scott sued C.R. Bard in 2009 over its Avaulta Plus mesh product.
In February 2013, Linda Gross won $11.11 million in her lawsuit against Johnson & Johnson’s Ethicon brand over its Prolift vaginal mesh product. Gross had 18 surgeries. The New Jersey jury found that J&J failed to warn patients and doctors about the risks of its mesh products and made fraudulent misrepresentations.
On August 15, 2013, after about 12 hours of deliberation, the jury found for Donna Cisson in her vaginal mesh trial against manufacturer C.R. Bard Inc, and found damages in the amount of $250,000 and $1.75 million in punitive damages. The jury found that Bard failed to provide adequate warnings as to the defects in its vaginal mesh product and that the device was defective. Judge Joseph Goodwin upheld the 2 million verdict in October 2013 as appropriate and that Cisson’s attorneys proved the company’s vaginal mesh was the cause of her injuries. In Queen vs. Bard, starting trial immediately after Cisson, a settlement was reached after the jury was selected. Finally, Bard settled Melanie Virgil’s claims that Bard’s Avaulta Plus insert caused urinary problems before trial commenced in New Jersey.
On February 18, 2014, Judge Joseph Goodwin granted Ethicon’s Motion for Directed Verdict at the close of Plaintiff’s case in Lewis vs. Ethicon, Inc. (In Re: Ethicon, Inc., Pelvic Repair System Products Liability Litigation, MDL Docket No. 2327, Carolyn Lewis, et al. v. Johnson & Johnson, et al., No. 2:12-4301, S.D. W.Va.).
On April 4, 2014, a Dallas jury found for the plaintiff Linda Batiste and ordered Johnson & Johnson to pay $1.2 million for its defective design of the Ethicon TVT-O pelvic mesh.
Two Massachusetts juries recently rejected women’s claims that Boston Scientific’s incontinence sling was defective designed and injured women.
On September 5, 2014, a federal jury in West Virginia found for the plaintiff Jo Huskey and ordered Johnson & Johnson’s Ethicon to pay $3.27 million.
On September 9, 2014, a Dallas federal jury found for the plaintiff Martha Salazar and awarded a verdict against Boston Scientific of $73 million, including $50 million in punitive damages, which was later reduced to$34 million.
On November 18, 2014, 4 Florida women were awarded $27 million against Boston Scientific.
Johnson & Johnson is a registered trademark of Johnson & Johnson Inc. The use of this trademark is solely for product identification and informational purposes. Johnson & Johnson Inc. is not affiliated with this website, and Johnson & Johnson Inc. has no affiliation with The Brandi Law Firm. Nothing on this site has been authorized or approved by Johnson & Johnson Inc.